MY191571A - Device for detecting igm antibodies against toxoplasma infection and method thereof - Google Patents

Device for detecting igm antibodies against toxoplasma infection and method thereof

Info

Publication number
MY191571A
MY191571A MYPI2017701091A MYPI2017701091A MY191571A MY 191571 A MY191571 A MY 191571A MY PI2017701091 A MYPI2017701091 A MY PI2017701091A MY PI2017701091 A MYPI2017701091 A MY PI2017701091A MY 191571 A MY191571 A MY 191571A
Authority
MY
Malaysia
Prior art keywords
detecting
antibodies against
toxoplasma infection
igm antibodies
infection
Prior art date
Application number
MYPI2017701091A
Inventor
Dr Rahmah Binti Noordin Professor
Hafiznur Bin Yunus Muhammad
Chiat Han Chang
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Priority to MYPI2017701091A priority Critical patent/MY191571A/en
Priority to PCT/MY2018/000005 priority patent/WO2018182397A1/en
Priority to PH12019550182A priority patent/PH12019550182A1/en
Publication of MY191571A publication Critical patent/MY191571A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/45—Toxoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

There is disclosed a method of a detecting an antibody directed against a Toxoplasma infection, in particular Toxoplasma gondii; the method comprising: providing a biological sample on a surface; contacting said sample with a detector reagent in a manner to allow the reagent to move from one end to another end on said surface; wherein the detector reagent includes a combination of two recombinant proteins that detect at least one type of antibody against at least one type of Toxoplasma gondii polypeptide. In one aspect of the present invention, there is provided a lateral flow device adapted for detecting a Toxoplasma infection comprising the use of two new recombinants, GRA7 and TgRA15. (FIG.1)
MYPI2017701091A 2017-03-29 2017-03-29 Device for detecting igm antibodies against toxoplasma infection and method thereof MY191571A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MYPI2017701091A MY191571A (en) 2017-03-29 2017-03-29 Device for detecting igm antibodies against toxoplasma infection and method thereof
PCT/MY2018/000005 WO2018182397A1 (en) 2017-03-29 2018-01-30 Device for detecting igm antibodies against toxoplasma infection and method thereof
PH12019550182A PH12019550182A1 (en) 2017-03-29 2019-09-19 Device for detecting igm antibodies against toxoplasma infection and method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2017701091A MY191571A (en) 2017-03-29 2017-03-29 Device for detecting igm antibodies against toxoplasma infection and method thereof

Publications (1)

Publication Number Publication Date
MY191571A true MY191571A (en) 2022-06-30

Family

ID=63677989

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017701091A MY191571A (en) 2017-03-29 2017-03-29 Device for detecting igm antibodies against toxoplasma infection and method thereof

Country Status (3)

Country Link
MY (1) MY191571A (en)
PH (1) PH12019550182A1 (en)
WO (1) WO2018182397A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061906A2 (en) * 1998-05-28 1999-12-02 Abbott Laboratories Toxoplasma gondii antigens, p35, and uses thereof
MY187731A (en) * 2014-10-16 2021-10-15 Univ Sains Malaysia In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy

Also Published As

Publication number Publication date
PH12019550182A1 (en) 2020-06-08
WO2018182397A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
MX2018009242A (en) Methods and apparatus for detecting compounds in liquids.
SG10201906750XA (en) Assays for detecting the presence or amount of an anti-drug antibody
SE1750227A1 (en) Chemiluminescent Protein Chip, KIT and Method for DetectingSeroglycoid Fucose Index
MX2009013411A (en) Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies.
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
MX2012007660A (en) Assay for jc virus antibodies.
MX2015012824A (en) Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection.
MX2016001573A (en) Assays for timp2 having improved performance in biological samples.
TW200740840A (en) Diagnostic test kits
EA201892325A1 (en) COMPOSITIONS AND METHODS OF DETECTING PROTEINS OF CELL-HOST
MX2016007350A (en) Assay device.
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
MX2021005902A (en) Cell-based method for determining botulinum toxin activity.
SG157244A1 (en) Point of care test for the detection of exposure or immunity to dengue virus
SG11201809558PA (en) Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same
MX2021003484A (en) Methods for detecting hook effect(s) associated with anaylte(s) of interest during or resulting from the conductance of diagnostic assay(s).
MX2016012079A (en) Device for detection of disease states and applications of same.
WO2008136510A1 (en) Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes
PH12019550182A1 (en) Device for detecting igm antibodies against toxoplasma infection and method thereof
WO2018172337A8 (en) Immunoassay for detecting zika virus infection
EA201390561A1 (en) ANALYTICAL DEVICE
EP4253950A3 (en) Ce-western applications for antibody development
MX2016013429A (en) Device and method for detecting blood group antigens by means of an incomplete antibody.
WO2017062535A3 (en) Borrelia immunoassays and materials therefor
WO2014126487A3 (en) Diagnosis and detection of dengue virus infection using chicken egg antibodies